Search Results

You are looking at 51 - 60 of 508 items for :

  • "pathology" x
  • Refine by Access: All x
Clear All
Full access

Abdul-Rahman Jazieh, Hanaa Bamefleh, Ahmet Demirkazik, Rabab Mohamed Gaafar, Fady B. Geara, Mansur Javaid, Jamal Khader, Kian Khodadad, Walid Omar, Ahmed Saadeddin, Hassan Al Sabe, Mohammad Behgam Shadmehr, Amgad El Sherif, Najam Uddin, Mohammad Jahanzeb, and David Ettinger

formed. The committee comprises various experts in thoracic oncology, including medical and clinical oncology, radiation oncology, pulmonology medicine, thoracic surgery, radiology, and pathology. The committee convened twice and corresponded frequently

Full access

Natasha Satkunam, Xuejiao Wei, James J. Biagi, Sulaiman Nanji, and Christopher M. Booth

Registry (OCR) to identify all incident cases of colorectal cancer (CRC) in Ontario diagnosed in 2000 to 2008. The OCR does not capture disease stage for all patients; therefore, we obtained surgical pathology reports for a random sample of 25% of cases

Full access

Christopher M. Booth, Sulaiman Nanji, Xuejiao Wei, Yingwei Peng, James J. Biagi, Timothy P. Hanna, Monika K. Krzyzanowska, and William J. Mackillop

during 2000–2008. The OCR does not capture stage of disease for all patients; therefore, we obtained surgical pathology reports for a random sample of 25% of cases. Reports were not available for patients with surgery in 2005; therefore, the study cohort

Full access

Dayna Crawford, Brook Blackmore, Jeremy Ortega, and Erica Williams

: By developing software that utilizes artificial intelligence, Sarah Cannon created an automated process to identify colon cancer patients at the time of diagnosis. This technology then routes positive pathology reports to a VCN who contacts the early

Full access

Yamini V. Ananth and Karisa Schreck

-based database using the REDCap tool. We analyzed data from 29 adults with primary brain tumors containing the BRAF V600E mutation, recording gender, age at diagnosis, tumor pathology, molecular tumor information, dates of surgeries, time to progression

Full access

Rafael López, Antonio Antón, Enrique Aranda, Alfredo Carrato, Manuel Constenla, Juan Jesús Cruz, Eduardo Díaz-Rubio, Margarita Feyjóo, Jesús García-Foncillas, Pere Gascón, Vicente Guillem, Ilse Lugo, Álvaro Rogado, and Carlos Camps

participation. Core and lung cancer modules were completed. Results: During the 6 rounds, 1,877 charts were submitted by the Spanish practices. In most of the rounds, the highest scores were: pathology report confirming malignancy; number of chemotherapy

Full access

Samantha Rios and Kelsey Larson

-up imaging and procedures, and final breast pathology were reviewed. Descriptive points were analyzed using counts and percentages versus mean with standard deviation where applicable. After review, 261 patients met inclusion and exclusion criteria with

Full access

Giuseppe Curigliano

.m. Patient: “Doctor, I’m terrified. The pathology report says ‘invasive carcinoma.’ ‘Invasive’ means cancer, doesn’t it? I’ll need chemotherapy. I’ll lose my hair. I won’t see my children grow up.” Across borders and social-cultural groups of patients, a

Full access

Siddhartha Yadav, Sri Harsha Tella, Anuhya Kommalapati, Kristin Mara, Kritika Prasai, Mohamed Hamdy Mady, Mohamed Hassan, Rory L. Smoot, Sean P. Cleary, Mark J. Truty, Lewis R. Roberts, and Amit Mahipal

diagnosis. 5 The current AJCC TNM staging system for GBC is primarily based on surgical pathology. 6 It relies on accurate evaluation of tumor infiltration into the layers of gallbladder, which can only be achieved through complete surgical excision of the

Full access

Jocelyn S. Chapman, Saurabh Asthana, Lindsay Cade, Matthew T. Chang, Zhen Wang, Charles J. Zaloudek, Stefanie Ueda, Eric A. Collisson, and Barry S. Taylor

*, and BRCA2 I605fs*11 ( Figure 2A ). Figure 1 Imaging and pathology reveal ambiguous diagnosis. (A) Coronal CT of the abdomen shows confluent retroperitoneal and porta hepatis lymphadenopathy (top arrows) resulting in moderate obstruction of the